Imagion Biosystems Limited (IBXXF)
Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform. Imagion's product pipeline includes MagSense, which is currently undergoing Phase I clinical trials for its application in HER2-positive breast cancer detection and management, as well as PrecisionMRX, an iron oxide nanoparticle engineered for general cancer detection. Imagion Biosystems also fosters strategic alliances, including a collaborative research program with Patrys Limited designed to integrate their respective technologies for improved imaging and diagnosis of brain tumors. Additionally, the company has a joint development agreement with Global Cancer Technology, Inc. to further develop GCT's novel nanoscintillator technology for the therapeutic treatment of breast cancer. The company was founded in 2016 and is headquartered in San Diego, California.
Sector: Medical - Diagnostics & Research
Industry: Medical - Diagnostics & Research
Imagion Biosystems Limited
- 1:40Reverse splitNov 16, 202340 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $0 | $1.8M | $3.36M | $2.07M | $1.93M | $139K | $278K | $129K | $14K | $8 | $4K | $4K |
| YoY Growth | - | -46.4% | 61.9% | 7.5% | 1288.1% | -49.9% | 114.6% | 852.5% | 167416.7% | -99.8% | -10.1% | - |
| Cost of Revenue | $6K | $271K | $3.55M | $2.44M | $1.83M | $1.93M | $1.53M | $2.23M | $0 | $15K | $0 | $0 |
| Gross Profit | -$6K | $1.53M | -$189K | -$368K | $102K | -$1.79M | -$1.26M | -$2.1M | $14K | -$15K | $4K | $4K |
| Gross Margin | - | 85.0% | -5.6% | -17.7% | 5.3% | -1290.6% | -452.3% | -1621.2% | 100.0% | -180250.0% | 100.0% | 100.0% |
| Research and Development | $1.42M | $271K | $3.55M | $2.44M | $1.83M | $1.93M | $1.53M | $2.23M | $1.46M | $339K | $2.62M | $1.51M |
| Selling, General, and Administrative | $176K | $1.77M | $6.95M | $3.73M | $2.54M | $1.91M | $1.23M | $2.68M | $1.84M | $29K | $166K | $59K |
| Other | $819K | $0 | $0 | $1.66M | $1.35M | $1.29M | $1.21M | $1.28M | $160K | $0 | $0 | $0 |
| Total Operating Expenses | $2.42M | $2.04M | $10.5M | $7.83M | $5.72M | $5.13M | $3.97M | $6.18M | $4.86M | $368K | $2.79M | $1.57M |
| Operating Income (EBIT) | -$2.42M | -$511K | -$10.69M | -$8.2M | -$5.62M | -$5.24M | -$2.31M | -$5.63M | -$4.63M | -$383K | -$2.79M | -$1.57M |
| Operating Margin | - | -28.4% | -318.1% | -395.3% | -291.2% | -3771.7% | -833.2% | -4351.6% | -34122.7% | -4721416.7% | -75100.0% | -37960.0% |
| Interest Expense | $572K | $772K | $762K | $1K | $3K | $4K | $6K | $5K | $632K | $0 | $0 | $0 |
| Interest Income | $22K | $7K | $47K | $20K | $7K | $0 | $15K | $25K | $55K | $0 | $186K | $132K |
| Other Income (Expense) | -$517K | -$885K | $2.26M | $1.58M | $1.55M | $1.62M | $1.38M | $417K | -$632K | -$316K | -$186K | -$132K |
| Income Before Tax (EBT) | -$2.94M | -$1.4M | -$8.43M | -$6.63M | -$4.07M | -$3.62M | -$2.32M | -$5.64M | -$5.27M | -$699K | -$2.97M | -$1.7M |
| Income Tax Expense | -$27K | $0 | $0 | $0 | $0 | $0 | $0 | $5K | $0 | -$1 | $0 | $0 |
| Net Income | -$2.91M | -$1.4M | -$8.43M | -$6.63M | -$4.07M | -$3.62M | -$2.32M | -$5.64M | -$5.27M | -$699K | -$2.97M | -$1.7M |
| Net Income Margin | - | -77.6% | -250.9% | -319.4% | -211.0% | -2607.5% | -835.5% | -4359.7% | -38775.3% | -8620641.7% | -80125.0% | -41160.0% |
| Supplementary Data | ||||||||||||
| EPS | -0.02 | -0.05 | -0.41 | -0.35 | -0.23 | -0.29 | -0.61 | -0.04 | -0.04 | -0.01 | -214.69 | -122.69 |
| Diluted EPS | -0.02 | -0.05 | -0.41 | -0.35 | -0.24 | -0.29 | -0.61 | -0.04 | -0.04 | -0.01 | -214.68 | -122.68 |
| Weighted Average OS | 277.47M | 44.94M | 30.48M | 28.03M | 26.19M | 18.68M | 8.98M | 234.27M | 183.55M | 102.64M | 20,499 | 20,499 |
| EBITDA | -$2.42M | -$240K | -$6.96M | -$5.77M | -$3.79M | -$3.31M | -$2.21M | -$5.49M | -$4.49M | -$527K | -$2.68M | -$1.53M |
| EBITDA Margin | - | -13.3% | -207.3% | -277.9% | -196.7% | -2381.1% | -796.5% | -4239.9% | -33093.7% | -6496766.7% | -72275.0% | -37180.0% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $1.25M | $1.8M | $153K | $3M | $9.05M | $8.92M | $2.3M | $2.95M | $4.64M | $8.05M | $263K | $110K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.25M | $1.8M | $153K | $3M | $9.05M | $8.92M | $2.3M | $2.95M | $4.64M | $8.05M | $263K | $110K |
| Accounts Receivable | $23K | $599 | $50K | $62K | $21K | $44K | $48 | $335K | $6K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $213K | $118K | $43K | $66K | -$240K | $230K | $0 | $0 | $0 |
| Other Current Assets | $4K | $22K | $107K | -$122K | -$3K | -$17K | -$17K | $240K | $32K | $0 | $0 | $0 |
| Total Current Assets | $1.37M | $1.88M | $406K | $3.37M | $9.3M | $9.08M | $2.41M | $3.32M | $4.91M | $8.06M | $263K | $110K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $6K | $12K | $2.69M | $3.37M | $234K | $463K | $878K | $184K | $251K | $148K | $270K | $119K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $6K | $12K | $2.69M | $3.37M | $234K | $463K | $878K | $184K | $251K | $148K | $270K | $119K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.38M | $1.89M | $3.1M | $6.74M | $9.54M | $9.54M | $3.29M | $3.5M | $5.16M | $8.2M | $533K | $229K |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $807K | $1.4M | $1.07M | $220K | $289K | $195K | $479K | $665K | $271K | $305K | $107K | $82K |
| Short-Term Debt | $1.71M | $1.89M | $1.15M | $0 | $0 | $0 | $0 | $0 | $0 | $9.41M | $4.1M | $766K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $188K | $0 | $0 | -$9.47M | $0 | $0 |
| Other Current Liabilities | $301K | $112K | $328K | $130K | $130K | $98K | -$46K | $138K | $110K | $338K | $0 | $0 |
| Total Current Liabilities | $2.84M | $3.44M | $3.46M | $1.17M | $524K | $609K | $867K | $878K | $432K | $305K | $4.2M | $848K |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $507K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.32M | $2.06M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $2K | $1K | $2K | $1K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $2.19M | $2.41M | $23K | $206K | $416K | $12K | $33K | $305K | $2.32M | $2.06M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$305K | $0 | $0 |
| Total Liabilities | $2.84M | $3.44M | $5.66M | $3.58M | $547K | $814K | $1.28M | $891K | $465K | $305K | $6.52M | $2.91M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $44.55M | $42.26M | $40.27M | $38.4M | $38.4M | $34.68M | $24.94M | $22.42M | $19.38M | $20.34M | $56K | $50K |
| Retained Earnings | -$48.17M | -$45.28M | -$46.16M | -$37.73M | -$31.1M | -$27.03M | -$23.41M | -$21.09M | -$15.45M | -$12.75M | -$6.04M | -$2.73M |
| Comprehensive Income & Other | $2.16M | $1.48M | $3.33M | $2.49M | $1.7M | $1.08M | $483K | $1.28M | $769K | $306K | $0 | $0 |
| Other Stockholders' Equity | $2.16M | $1.48M | $3.33M | $2.49M | $1.7M | $1.08M | $483K | $1.28M | $769K | $306K | $0 | $0 |
| Total Equity | -$1.46M | -$1.54M | -$2.56M | $3.16M | $8.99M | $8.73M | $2.01M | $2.61M | $4.7M | $7.9M | -$5.99M | -$2.68M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.38M | $1.89M | $3.1M | $6.74M | $9.54M | $9.54M | $3.29M | $3.5M | $5.16M | $8.2M | $533K | $229K |
| Supplementary Data | ||||||||||||
| Total Debt | $1.73M | $1.92M | $4.08M | $3.11M | $31K | $447K | $592K | $37K | $54K | $9.41M | $6.41M | $2.83M |
| Net Debt | $484K | $119K | $3.93M | $107K | -$9.02M | -$8.47M | -$1.71M | -$2.91M | -$4.59M | $1.36M | $6.15M | $2.72M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$2.91M | -$1.4M | -$8.43M | -$6.63M | -$4.07M | -$3.62M | -$2.32M | -$5.64M | -$5.27M | -$699K | -$2.97M | -$1.7M |
| Depreciation & Amortization | $6K | $265K | $799K | $742K | $273K | $244K | $96K | $144K | $140K | $15K | $105K | $32K |
| Deferred Income Tax | $0 | $0 | $0 | -$6.3M | -$850K | -$944K | $346K | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $8K | $313K | $441K | $336K | $286K | -$715K | $566K | $422K | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$10K | $49K | $250K | -$134K | -$23K | -$45K | $16K | -$30K | -$45K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$490K | $0 | $1.2M | $114K | $56K | -$126K | -$202K | $251K | -$246K | $217K | $0 | $0 |
| Other Working Capital | $0 | $0 | $0 | $0 | $0 | $0 | -$30K | $194K | -$224K | $29K | -$47K | -$16K |
| Total Working Capital Change | -$500K | $49K | $1.45M | -$20K | $32K | -$170K | -$216K | $415K | -$515K | $211K | -$47K | -$16K |
| Other Non-Cash Items | $674K | $216K | $243K | $6.31M | $854K | $1.08M | -$18K | $5.5M | $5.13M | $105K | $62K | $40K |
| Net Cash from Operating | -$2.73M | -$859K | -$5.62M | -$5.46M | -$3.42M | -$3.12M | -$2.83M | -$5.5M | -$4.71M | -$181K | -$2.85M | -$1.64M |
| Investing Activities | ||||||||||||
| Capital Expenditures | $0 | $57K | -$129K | -$343K | -$148K | -$5K | -$8K | -$56K | -$250K | $0 | -$241K | -$30K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $26K | -$62K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $57K | -$129K | -$317K | -$210K | -$5K | -$8K | -$56K | -$250K | $0 | -$241K | -$30K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | -$457K | -$2.36M | $652K | $243K | -$158K | -$57K | - | -$77K | - | - | -$826K |
| Common Stock Issuance | $2.19M | $2.11M | $1.61M | $2K | $3.72M | $10.88M | $2.28M | $2.9M | $12.3M | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$4K | -$905K | -$9K | -$37K | -$750K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$130K | -$1.08M | $0 | $0 | -$325K | -$81K | -$87K | -$67K | $156K | $3.23M | $643K |
| Net Cash from Financing | $2.19M | $2.44M | $2.9M | -$650K | $3.48M | $9.81M | $2.25M | $2.77M | $9.58M | $156K | $3.23M | $1.47M |
| Forex Effect | $117K | $14K | -$3K | $377K | $288K | -$61K | -$65K | $28K | $5K | -$135K | $0 | $0 |
| Net Change in Cash | -$424K | $1.65M | -$2.85M | -$6.05M | $131K | $6.62M | -$652K | -$1.69M | $4.63M | -$244K | $153K | -$203K |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$2.73M | -$859K | -$5.62M | -$5.88M | -$3.42M | -$3.12M | -$2.83M | -$5.5M | -$4.71M | -$181K | -$2.85M | -$1.64M |
| Capital Expenditure | $3 | $0 | -$129K | -$343K | -$148K | -$5K | -$8K | -$56K | -$250K | $0 | -$241K | -$30K |
| Free Cash Flow | -$2.73M | -$859K | -$5.75M | -$6.22M | -$3.57M | -$3.13M | -$2.83M | -$5.55M | -$4.96M | -$181K | -$3.1M | -$1.67M |
| Cash at Beginning | $1.67M | $153K | $3M | $9.05M | $8.92M | $2.3M | $2.95M | $4.64M | $19K | $263K | $110K | $313K |
| Cash at End | $1.25M | $1.8M | $153K | $3M | $9.05M | $8.92M | $2.3M | $2.95M | $4.64M | $19K | $263K | $110K |